title: The Lymphatic Endothelial mCLCA1 Antibody Induces Proliferation and Growth of Lymph Node Lymphatic Sinuses.
abstract: Lymphocyte- and leukocyte-mediated lymph node (LN) lymphatic sinus growth (lymphangiogenesis) is involved in immune responses and in diseases including cancer and arthritis. We previously discovered a 10.1.1 Ab that recognizes the lymphatic endothelial cell (LEC) surface protein mCLCA1, which is an interacting partner for LFA1 and Mac-1 that mediates lymphocyte adhesion to LECs. Here, we show that 10.1.1 Ab treatment specifically induces LEC proliferation, and influences migration and adhesion in vitro. Functional testing by injection of mice with 10.1.1 Ab but not control hamster Abs identified rapid induction of LN LEC proliferation and extensive lymphangiogenesis within 23 h. BrdU pulse-chase analysis demonstrated incorporation of proliferating LYVE-1-positive LEC into the growing medullary lymphatic sinuses. The 10.1.1 Ab-induced LN remodeling involved coordinate increases in LECs and also blood endothelial cells, fibroblastic reticular cells, and double negative stroma, as is observed during the LN response to inflammation. 10.1.1 Ab-induced lymphangiogenesis was restricted to LNs, as mCLCA1-expressing lymphatic vessels of the jejunum and dermis were unaffected by 23 h 10.1.1 Ab treatment. These findings demonstrate that 10.1.1 Ab rapidly and specifically induces proliferation and growth of LN lymphatic sinuses and stroma, suggesting a key role of mCLCA1 in coordinating LN remodeling during immune responses.
authors.affiliation: Department of Comparative Medicine, University of Washington, Seattle, WA, United States of America.
authors.forename: Kimberly L
authors.initials: KL
authors.lastname: Jordan-Williams
authors.affiliation: Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
authors.forename: Neela
authors.initials: N
authors.lastname: Ramanujam
authors.affiliation: Department of Biological Structure, University of Washington, Seattle, WA, United States of America.
authors.forename: Andrew G
authors.initials: AG
authors.lastname: Farr
authors.affiliation: Department of Comparative Medicine, University of Washington, Seattle, WA, United States of America.|Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
authors.forename: Alanna
authors.identifier: 0000-0002-0195-5576
authors.initials: A
authors.lastname: Ruddell
mesh_terms: D000818:Animals; D000906:Antibodies / Q000276:immunology / Q000494:pharmacology*; D049109:Cell Proliferation / Q000187:drug effects*; D018118:Chloride Channels / Q000037:antagonists & inhibitors* / Q000276:immunology; D020405:Dermis / Q000166:cytology / Q000276:immunology; D004729:Endothelium, Lymphatic / Q000166:cytology / Q000276:immunology*; D007583:Jejunum / Q000166:cytology / Q000276:immunology; D008198:Lymph Nodes / Q000276:immunology*; D042583:Lymphangiogenesis / Q000187:drug effects* / Q000276:immunology; D051379:Mice
chemical_list: D000906:Antibodies; D018118:Chloride Channels; C116464:Clca3a1 protein, mouse